Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.60    -0.20 (-0.08%)
Bid:
254.00
Ask:
254.80
Spread: 0.80 (0.315%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share Repurchase Programme

5 Mar 2024 07:00

RNS Number : 5397F
Serco Group PLC
05 March 2024
 

5 March 2024

LEI: 549300PT2CIHYN5GWJ21

Serco Group plc

(Serco or the Company)

Share Repurchase Programme

Serco today announces that, as outlined in the announcement of its 2023 Full Year Results on 29 February 2024, it intends to repurchase shares with a value of up to £140 million (the Programme).

Serco has instructed Barclays Capital Securities Limited (Barclays) and J.P. Morgan Securities plc (JPMS), together the Brokers, to execute the Programme.

Serco has entered into a non-discretionary and irrevocable instruction with Barclays in relation to the purchase by Barclays, acting as riskless principal during the period commencing today and ending no later than 5 August 2024, of the Company's Ordinary Shares of 2 pence each (Ordinary Shares) for an aggregate purchase price of up to £70 million. Following completion, or any termination of such instruction, the Programme will continue under a second non-discretionary and irrevocable instruction with JPMS in relation to the purchase by JPMS, acting as riskless principal during the period commencing following the end of the Barclays instruction and ending no later than 31 December 2024, subject to suspension for certain exceptional and/or unforeseen circumstances, of further Ordinary Shares for an aggregate purchase price of up to £70 million.

The aggregate number of shares acquired by the Company shall not exceed 115,617,039 Ordinary Shares as authorised by shareholders at the 2023 Annual General Meeting. It is intended that any Ordinary Shares purchased under the Programme will be transferred into treasury and subsequently cancelled. This arrangement is in accordance with Chapter 12 of the Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.

The aggregate purchase price of the Ordinary Shares bought by the Brokers under the two instructions shall be no greater than £140 million. Each of the Brokers shall make a simultaneous on-sale of Ordinary Shares purchased under the instructions to Serco. The Brokers will make their trading decisions in relation to the Programme independently of, and uninfluenced by, Serco.

The Brokers may undertake transactions in Ordinary Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by the relevant Broker as a result of or as part of the Programme, but the Brokers will continue to make any disclosures they are otherwise legally required to make.

Ends

 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com

 

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world. With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management. Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSAWRSKUORAR
Date   Source Headline
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 202510:04 amRNSDirector Declaration
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20255:00 pmRNSDirector/PDMR Shareholding
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20255:40 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20255:00 pmRNSHolding(s) in Company
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20256:19 pmRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20259:30 amRNSUpdate Statement on 2025 AGM Voting Results
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20253:00 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20253:00 pmRNSStatement re shareholder consultation
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20252:00 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20254:00 pmRNSHolding(s) in Company
12th Aug 202510:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSShare Repurchase Programme
8th Aug 20255:00 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNS2025 half year results
26th Jun 20257:01 amRNSSerco appoints Keith Williams as Board Chair
26th Jun 20257:00 amRNSSerco pre-close trading update
30th May 20259:30 amRNSBlock listing Interim Review
27th May 20257:00 amRNSSerco completes acquisition of MTS
15th May 20257:00 amRNSSerco awarded Maritime Services contracts
13th May 20251:00 pmRNSDirector/PDMR Shareholding
9th May 20253:00 pmRNSDirector/PDMR Shareholding
24th Apr 202512:18 pmRNSResult of AGM and Director Declaration
9th Apr 20255:00 pmRNSDirector/PDMR Shareholding
7th Apr 20255:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.